Following blood transfusion, there is a risk of transfusion-transmitted infectious diseases (TTID), despite current advanced screening technologies. Infectious agents involved are very diverse and include hepatitis B (HBV), hepatitis C (HCV), human immunodeficiency (HIV-1/2), human T-cell lymphotropic (HTLV-I/II), Cytomegalo- (CMV), Parvo- B19, West Nile (WNV) and Dengue viruses. Trypanosomiasis, malaria, and Transmissible Spongiform Encephalopathy (TSE) also belong to TTID. TTID can be reduced by donor exclusion, screening for serological infection markers or nucleic acid testing (NAT) by viral gene amplification. Despite this, blood-borne infectious agents are transmitted through transfusion of infected blood donated by apparently healthy and asymptomatic blood donors.

 

Current Leadership

Brian Custer

Brian Custer

TTID Working Party Chair, Director, Vitalant Research Institute, Senior Vice President Research and Affiliate Professor, Laboratory Medicine, UCSF, San Francisco, CA, USA

Sheila O’Brien

Sheila O’Brien

ISBT TTID WP Vice Chair, Associate Director, Epidemiology and Surveillance at Canadian Blood Service, Ottawa, Canada

Michel Andrés García Otálora

Michel Andrés García Otálora

ISBT TTID WP Secretary, Associate Professor, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia. Contractor Physician, Hemovigilance Program, National Network of Blood Banks and Transfusion Services, Instituto Nacional de Salud, Bogotá, Colombia

Marion Vermeulen

Marion Vermeulen

ISBT Regional Director Africa, Individual Member Representative at the ISBT TTID WP, Executive, Transfusion Medicine and Technical Services, South African National Blood Service (SANBS)

Michael Schmidt

Michael Schmidt

Individual Member Representative at the ISBT TTID WP, Head, Quality Management and Blood Donor Screening, German Red Cross Blood Service Baden-Wuerttemberg, Germany

Marcia Cardoso

Marcia Cardoso

ISBT Corporate Member Representative at TTID WP, Global Senior Medical Affairs Manager, Terumo Blood and Cell Technologies

Annual Report 

Click the link below to read the Report of the TTID Working Party for 2024/2025.